These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9026840)

  • 21. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
    Ushiroyama T; Sakuma K; Nosaka S
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):142-8. PubMed ID: 16891292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
    Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
    J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization.
    O'Connor PJ; Rush WA; Trence DL
    J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and an update on trials now in progress.
    Ericsson CG
    Eur Heart J; 1998 Jul; 19 Suppl H():H37-41. PubMed ID: 9717064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherogenic risk reduction in patients with dyslipidaemia. comparison between bezafibrate and lovastatin.
    Sinzinger H; Pirich C; Kondor P; Etti H
    Eur Heart J; 1995 Nov; 16(11):1491-501. PubMed ID: 8881840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia].
    Tonstad S; Gørbitz C; Ose L; Malt UF
    Tidsskr Nor Laegeforen; 1994 Aug; 114(19):2262-4. PubMed ID: 7992293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations.
    Ballantyne CM; Radovancevic B; Farmer JA; Frazier OH; Chandler L; Payton-Ross C; Cocanougher B; Jones PH; Young JB; Gotto AM
    J Am Coll Cardiol; 1992 May; 19(6):1315-21. PubMed ID: 1564233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin.
    Gullestad L; Nordal KP; Forfang K; Ihlen H; Høstmark A; Berg KJ; Cheng H; Schwartz MS; Geiran O; Simonsen S
    J Intern Med; 1997 Dec; 242(6):483-90. PubMed ID: 9437409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of lovastatin and bezafibrate on lipoprotein(a) plasma levels in cardiac transplant recipients.
    Perez-Jimenez F; Hidalgo L; Zambrana JL; Arizon JM; Jimenez-Pereperez JA; Concha M; Espino A; Blanco J; Valles F; Lopez-Miranda J
    Am J Cardiol; 1995 Mar; 75(8):648-50. PubMed ID: 7887403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidemia after heart transplantation.
    Keogh A; Simons L; Spratt P; Esmore D; Chang V; Hickie J; Baron D
    J Heart Transplant; 1988; 7(3):171-5. PubMed ID: 3290399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin).
    Ballantyne CM; Jones PH; Payton-Ross C; Patsch W; Short HD; Noon GP; Gotto AM; DeBakey ME; Young JB
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):60-2. PubMed ID: 3303569
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term bezafibrate treatment in a lipid clinic].
    Yeshurun D; Abukarshin R; Ellias N; Naschitz JE
    Harefuah; 1992 May; 122(10):632-4, 687. PubMed ID: 1526540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.